Robert Macdonald

Robert Macdonald

Directeur Technique/Scientifique/R&D chez GRACE THERAPEUTICS, INC.

Fortune : - $ au 31/05/2026

64 ans
Health Services
Consumer Services
Health Technology

Profil

Robert Loch Macdonald was the founder of Edge Therapeutics, Inc. since 2009, serving as Director & Chief Scientific Officer.
Current job includes Medical Director at Community Health Partners since 2021 and Chief Medical Officer at Grace Therapeutics, Inc. since 2023.
Former jobs include Professor at The University of Chicago Medical Center from 2019 to 2021, Head-Neurosurgery Division at St. Michael's Hospital from 2007 to 2015, Professor at California State University-Fresno from 2019 to 2021, Professor at the University of Toronto from 2007 to 2019, and Professor at Barrow Neurological Institute in 2018.
Education includes a doctorate from the University of Alberta and a graduate degree from the University of British Columbia.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
14/04/2025 0 ( -.--% ) - $ 31/05/2026

Postes actifs de Robert Macdonald

SociétésPosteDébut
GRACE THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 08/05/2023
Corporate Officer/Principal 01/10/2021

Anciens postes connus de Robert Macdonald

SociétésPosteFin
Corporate Officer/Principal 01/09/2021
Corporate Officer/Principal 01/10/2019
Corporate Officer/Principal 01/08/2018
Fondateur 15/05/2018
Corporate Officer/Principal 01/12/2015
Voir l'expérience en détail de Robert Macdonald

Formation de Robert Macdonald

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

91

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Services

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Services

Health Services

  1. Bourse
  2. Insiders
  3. Robert Macdonald
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT